Conference Menu

Overview
Day 1
Day 2
Short Course
Posters
Hotel & Travel
View Exhibitors/Floor Plan
Contact Us
Registration


Premier Sponsor:

OpenEye_Vertical

Corporate Sponsor:

Schrodinger logo

Media Sponsor:

Bio-IT-Word

Sponsoring Society:

ISCB

Lead Sponsoring Publications:

Clinical Informatics News

Gen

Insight Pharma Reports

nature

PharmaVoice

Science AAAS
Scientific Computing Logo Small

The Scientist

Web Partners:

FierceBiotech

Fierce Biotech IT

FiercePharma

GenomeWeb

Structure-Based Drug Design 2014
21 May, 2014 - 22 May, 2014 Westin Boston Waterfront, Boston, MA, USA


CHI's Fourteenth Annual Structure-Based Drug Design Conference - Overview




Experimental methods such as X-ray crystallography, NMR, and computational chemistry techniques have led to a better understanding and larger knowledge base of 3-dimensional structures and binding events, encouraging rapid development of structure-based drug design. Cambridge Healthtech Institute’s Fourteenth Annual Structure-Based Drug Design event will showcase informative, high-quality case studies, innovative techniques, and strategies to move from computation to experiment, and finally, to drug. Top scientists from pharma and biotech will address how they are hitting epigenetic targets, provide updates on the newest wave of GPCRs and other membrane proteins, and discuss the latest in fragment-based drug design. Attendees will return to their organizations with fresh perspectives and new ideas to maximize productivity and increase successes in drug discovery.

Keynote Speaker 

Chas BountraChas Bountra, Ph.D.

Professor, Translational Medicine, Department of Clinical Medicine; Associate Head, Medical Sciences; Chief Scientist, Structural Genomics Consortium, University of Oxford

 

What’s New This Year:

  • Coverage of novel targets and compounds including macrocycles, epigenetic targets, and BACE inhibitors
  • Case studies and experimental follow-up - see how Constellation, Heptares, AstraZeneca, and others are leading the SBDD charge
  • Expanded sessions on GPCR design and drug discovery
  • Showcase of different approaches for working with the similar targets
 

Hear up-to-the-minute case studies from:

  • Arena Pharmaceuticals
  • Astex
  • AstraZeneca
  • Bristol-Myers Squibb
  • Carmolex
  • Carmot Therapeutics
  • Constellation Pharmaceuticals
  • Genentech
  • Heptares Therapeutics UK
  • Merck
  • Novartis
  • Structural Genomics Consortium
  • Takeda
  • Vernalis, Ltd.

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Catalog

Industry Event Calendar


Global Information, Inc. - International Marketing Partner of Cambridge Healthtech Institute